Interactive Investor
>>

Verici Dx Ordinary Shares (LSE:VRCI) Share Price

VRCI

Verici Dx Ordinary Shares

UK company

Right Arrow 1

Healthcare

Right Arrow 2

Diagnostics & Research

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XLON

-

Updated: -

Research

News & analysis

Regulatory news

Loading...

Times are shown in BST, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies which will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialisation: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection ("EAR"); and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels.

LSE:VRCI

GB00BM8HZD43

GBX

Loading...

Loading Comparison

Latest VRCI News

VRCI Regulatory News